Freiburg Initiative for Systems Biology Performs Transcriptomics with Genedata Expressionist

Genomic Profiling Software, used in Physcomitrella patens Transcriptomics, will be featured at Next Generation Sequencing Congress

London, UK, November 15, 2010

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that the Freiburg Initiative for Systems Biology (FRISYS) is using the Genedata Expressionist Refiner Genome module to analyze and unify transcriptomics of the Physcomitrella patens (P. patens) genome. P. patens genome profiling is vital to moss gene research, which can advance crop improvements and the safe production of biopharmaceuticals. Leading this research is the University of Freiburg’s FRISYS, one of four systems biology centers funded by the German Federal Ministry of Education and Research. Genedata Expressionist for genomic profiling will be demonstrated at the Next Generation Sequencing Congress (Radisson Edwardian Heathrow; Nov. 15 – 16).

“One of Genedata Expressionist’s advantages is that it enables researchers to quickly and easily compare expression data from various technology platforms in a unified system,” noted Dr. Stefan Rensing, FRISYS lecturer in bioinformatics and systems biology at the University of Freiburg. Built on the Genedata Expressionist proven workflow architecture, Genedata Expressionist Refiner Genome module provides a unified system for integration, processing, analysis, visualization, and management of terabytes of data in a genomic context. Its workflow system combined with an interactive genome browser creates a communications platform for scientists and statisticians alike.

Genedata Expressionist workflows, as used by FRISYS, can be built and shared within an enterprise to standardize research methodologies and increase productivity. “Genedata Expressionist simplifies and automates analyses traditionally handled by a bioinformatician,” continued Rensing, “therefore, it enables biologists to conduct analyses on their own, independent of bioinformaticians, and quickly gain the information they need from next-generation sequencing data.”

“FRISYS’s adoption of Genedata Expressionist advances a long-standing scientific collaboration between Genedata and the University of Freiburg,” said Dr. Othmar Pfannes. “This collaboration not only helps to drive our development of advanced software solutions, more importantly, it spearheads research that improves agribiotechnology and helps bring life-saving pharmaceuticals to market.”

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions for drug discovery, industrial biotechnology, and life science research. Used by a majority of the world’s top 50 pharmaceutical companies and leading research organizations, Genedata solutions make research data accessible and understandable, enabling scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Japan, Germany, and the US. www.genedata.com

Contacts

Allison Kurz
Genedata
Marketing & Communications
Phone: +41 61 511 8459
communications@genedata.com

Jackie Thrasivoulos
Genedata
Public Relations
Phone: +1 508 881 3109
jackie.thrasivoulos@genedata.com

Disclaimer

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.